#DNA

A research team believes fragmentomics has several advantages when it comes to liquid biopsies for cancer detection.

EBV can persist in our bodies for years and cause increased risk for certain cancers, such as lymphoma, leukemia, and head and neck cancer.

New visualization tool allows researchers to compare tumor types and normal brain tissue and pinpoint cancer-promoting alterations.

The human papillomavirus (HPV) genome can insert itself into host chromosomes and “turn on” tumor-causing genes.

All alcoholic drinks—even wine—are carcinogenic.

For diseases like cancer, which arise when certain genes are over- or underexpressed, this could open a “new world” of treatment options.

Understanding cancer DNA evolution is key to developing targeted therapies.

A new study proposes using circulating tumor DNA as a biomarker to guide chemotherapy treatment decisions for CRC patients.

Some people have inherited genetic syndromes that increase their risk for colon cancer.

Study finds that risk of adverse side effects from cancer immunotherapy is higher in patients with certain inherited genetic variations.

A number of mutations can drive myeloproliferative neoplasms.

Scientists map the genetic evolution of chronic lymphocytic leukemia (CLL) to Richter’s Syndrome.

In the near future, it may be possible to design specific diets tailored to individual genomic profiles to starve tumors.

Routine screening can detect colorectal cancer at an early stage, when it’s easier to treat.

A recent study offers good news about non-invasive stool-based colorectal cancer screening tools.

It is estimated that 106,180 new colon cancer cases and 44,850 new rectal cancer cases will be diagnosed in the U.S. this year.